Hee Jung Chun

Hee Jung Chun appears in our data through filings on THC Biomed Intl Ltd. shares, published by SEDI. In total, 95 filings cover trades dated from 14 January 2014 to 16 June 2022.

In open-market terms, that means 33 purchases worth €4,272 on one side and 49 sales worth €1.4M on the other. Taken together, the sales exceed the purchases by €1.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 option exercise. Since January 2022: 33 purchases and no sales on the market.

In size, the median ticket on the buying side is €102. Across 14 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 20 June 2022, reports an open-market purchase of €186 in THC Biomed Intl Ltd. Filings reach the SEDI feed a median of 5 days after the trade. Until a filing is published, the market cannot know about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEDI disclosures alone and does not predict where the share price will go.